Iconix Inks Biomarker Research Deal with Brigham and Women s Hospital Researcher | GenomeWeb

NEW YORK, Sept. 20 (GenomeWeb News) - Iconix Pharmaceuticals said today that it has signed an agreement to work with Roderick Jensen, acting director of the biotechnology center and laboratory for functional genomics at the Brigham and Women's Hospital, on the study and validation of gene expression patterns in patients with neurological diseases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic analysis of pollutant-tolerant fish, and more.

Researchers have found a rare carbapenem resistance gene on a US pig farm, NBC News reports.

New York officials are considering the use of a familial DNA search to get a lead on a suspect in the strangulation death of a runner.

NIH Director Francis Collins has selected a retired Army major general and cardiologist for the CEO spot at the agency's embattled Clinical Center.